The authors request to correct the project number NRF-2013R1A1A1010734 from NRF-116436 on the 4th line of Acknowledgments section.
Footnotes
DOI of original article: http://dx.doi.org/10.4062/biomolther.2014.078
. 2014 Sep 30;22(5):475. doi: 10.4062/biomolther.2014.475
Erratum to “Microfluidic System Based High Throughput Drug Screening System for Curcumin/TRAIL Combinational Chemotherapy in Human Prostate Cancer PC3 Cells” [Biomol. Ther. 22 (2014) 355–362]
Dami An
1, Kwangmi Kim
2, Jeongyun Kim
1,*
Kwangmi Kim
2College of Pharmacy, Dankook University, Cheonan 330-714, Republic of Korea
Find articles by Kwangmi Kim
1Department of Nanobiomedical Science
2College of Pharmacy, Dankook University, Cheonan 330-714, Republic of Korea
*
Corresponding Author: E-mail: jeongyunkim@dankook.ac.kr, Tel: +82-41-550-1255, Fax: +82-41-561-1256
Issue date 2014 Sep.
Copyright ©2014, The Korean Society of Applied Pharmacology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC4201230 PMID: 25412825
This corrects the article "Microfluidic System Based High Throughput Drug Screening System for Curcumin/TRAIL Combinational Chemotherapy in Human Prostate Cancer PC3 Cells" on page 355.